Ellington Management Group’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-19,200
Closed -$307K 780
2017
Q2
$307K Buy
+19,200
New +$307K 0.04% 381